Nanovibronix (NASDAQ:NAOV) Share Price Crosses Below Fifty Day Moving Average – Here’s What Happened

Nanovibronix, Inc. (NASDAQ:NAOV)’s share price passed below its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of $5.87 and traded as low as $3.80. Nanovibronix shares last traded at $3.80, with a volume of 12,453 shares.

Analysts Set New Price Targets

NAOV has been the subject of several recent research reports. Wall Street Zen raised shares of Nanovibronix from a “sell” rating to a “hold” rating in a research report on Saturday. Weiss Ratings reiterated a “sell (e+)” rating on shares of Nanovibronix in a report on Wednesday, October 8th. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat, the stock currently has an average rating of “Sell”.

Nanovibronix Stock Performance

The stock’s 50-day simple moving average is $5.81 and its 200 day simple moving average is $9.06. The company has a market capitalization of $4.07 million, a PE ratio of -0.09 and a beta of 2.16.

Nanovibronix (NASDAQ:NAOV) last released its quarterly earnings data on Friday, November 14th. The company reported ($0.91) earnings per share (EPS) for the quarter. The firm had revenue of $0.72 million for the quarter. Nanovibronix had a negative return on equity of 45.24% and a negative net margin of 380.29%.

Nanovibronix Company Profile

NanoVibronix, Inc, through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its product portfolio includes UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use.